Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity

Abstract

Allergic airway inflammation is associated with activation of innate immune pathways by allergens. Acute exacerbations of asthma are commonly associated with rhinovirus infection. Here we show that, after exposure to house dust mite (HDM) or rhinovirus infection, the E3 ubiquitin ligase midline 1 (MID1) is upregulated in mouse bronchial epithelium. HDM regulates MID1 expression in a Toll-like receptor 4 (TLR4)– and tumor necrosis factor–related apoptosis-inducing ligand (TRAIL)-dependent manner. MID1 decreases protein phosphatase 2A (PP2A) activity through association with its catalytic subunit PP2Ac. siRNA-mediated knockdown of MID1 or pharmacological activation of PP2A using a nonphosphorylatable FTY720 analog in mice exposed to HDM reduces airway hyperreactivity and inflammation, including the expression of interleukin-25 (IL-25), IL-33 and CCL20, IL-5 and IL-13 release, nuclear factor (NF)κB activity, p38 mitogen-activated protein kinase (MAPK) phosphorylation, accumulation of eosinophils, T lymphocytes and myeloid dendritic cells, and the number of mucus-producing cells. MID1 inhibition also limited rhinovirus-induced exacerbation of allergic airway disease. We found that MID1 was upregulated in primary human bronchial epithelial cells upon HDM or rhinovirus exposure, and this correlated with TRAIL and CCL20 expression. Together, these findings identify a key role of MID1 in allergic airway inflammation and links innate immune pathway activation to the development and exacerbation of asthma.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: MID1 silencing reduces allergen-induced airway hyperreactivity, allergic inflammation and increases PP2A activity.
Figure 2: Pharmacological activation of PP2A decreases HDM-induced airway hyperreactivity and allergic airway inflammation.
Figure 3: MID1 inhibition attenuates rhinovirus-induced airway inflammation and asthma exacerbations.
Figure 4: MID1 in allergen and rhinovirus exposed human airway epithelial cells.

Similar content being viewed by others

Accession codes

Accessions

ArrayExpress

References

  1. Lemanske, R.F. Jr. & Busse, W.W. Asthma: clinical expression and molecular mechanisms. J. Allergy Clin. Immunol. 125, S95–S102 (2010).

    Article  Google Scholar 

  2. Holgate, S.T., Roberts, G., Arshad, H.S., Howarth, P.H. & Davies, D.E. The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis. Proc. Am. Thorac. Soc. 6, 655–659 (2009).

    Article  CAS  Google Scholar 

  3. Lambrecht, B.N. & Hammad, H. Biology of lung dendritic cells at the origin of asthma. Immunity 31, 412–424 (2009).

    Article  CAS  Google Scholar 

  4. Weckmann, M. et al. Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease. Nat. Med. 13, 1308–1315 (2007).

    Article  CAS  Google Scholar 

  5. Wills-Karp, M. et al. Interleukin-13: central mediator of allergic asthma. Science 282, 2258–2261 (1998).

    Article  CAS  Google Scholar 

  6. Kuperman, D.A. et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8, 885–889 (2002).

    Article  CAS  Google Scholar 

  7. Mattes, J. et al. IL-13 induces airways hyperreactivity independently of the IL-4R alpha chain in the allergic lung. J. Immunol. 167, 1683–1692 (2001).

    Article  CAS  Google Scholar 

  8. Kuperman, D., Schofield, B., Wills-Karp, M. & Grusby, M.J. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J. Exp. Med. 187, 939–948 (1998).

    Article  CAS  Google Scholar 

  9. Johnston, S.L. et al. Community study of role of viral infections in exacerbations of asthma in 9–11 year old children. Br. Med. J. 310, 1225–1229 (1995).

    Article  CAS  Google Scholar 

  10. Kusel, M.M. et al. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr. Infect. Dis. J. 25, 680–686 (2006).

    Article  Google Scholar 

  11. Jackson, D.J. et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am. J. Respir. Crit. Care Med. 178, 667–672 (2008).

    Article  Google Scholar 

  12. Wark, P.A. et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 201, 937–947 (2005).

    Article  CAS  Google Scholar 

  13. Contoli, M. et al. Role of deficient type III interferon-λ production in asthma exacerbations. Nat. Med. 12, 1023–1026 (2006).

    Article  CAS  Google Scholar 

  14. Holgate, S.T. A look at the pathogenesis of asthma: the need for a change in direction. Discov. Med. 9, 439–447 (2010).

    PubMed  Google Scholar 

  15. Crimi, E. et al. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am. J. Respir. Crit. Care Med. 157, 4–9 (1998).

    Article  CAS  Google Scholar 

  16. Phipps, S. et al. Toll/IL-1 signaling is critical for house dust mite-specific TH1 and TH2 responses. Am. J. Respir. Crit. Care Med. 179, 883–893 (2009).

    Article  CAS  Google Scholar 

  17. Hammad, H. et al. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat. Med. 15, 410–416 (2009).

    Article  CAS  Google Scholar 

  18. Mattes, J., Collison, A., Plank, M., Phipps, S. & Foster, P.S. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc. Natl. Acad. Sci. USA 106, 18704–18709 (2009).

    Article  CAS  Google Scholar 

  19. Kumar, H., Kawai, T. & Akira, S. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388, 621–625 (2009).

    Article  CAS  Google Scholar 

  20. Fontanella, B., Russolillo, G. & Meroni, G. MID1 mutations in patients with X-linked Opitz G/BBB syndrome. Hum. Mutat. 29, 584–594 (2008).

    Article  CAS  Google Scholar 

  21. Latta, E.J. & Golding, J.P. Regulation of PP2A activity by Mid1 controls cranial neural crest speed and gangliogenesis. Mech Dev. 128, 560–576 (2012).

    Article  CAS  Google Scholar 

  22. Aranda-Orgillés, B. et al. Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A. PLoS ONE 3, e3507 (2008).

    Article  Google Scholar 

  23. McConnell, J.L. et al. α4 is a ubiquitin-binding protein that regulates protein serine/threonine phosphatase 2A ubiquitination. Biochemistry 49, 1713–1718 (2010).

    Article  CAS  Google Scholar 

  24. Trockenbacher, A., Suckow, V., Foerster, J., Winter, J. & Krauss, S. MID1, mutation in Opitz syndrome, encodes an ubiquitin ligase that targets phophatase 2A for degradation. Nat. Genet. 29, 287–294 (2001).

    Article  CAS  Google Scholar 

  25. Watkins, G.R. et al. Monoubiquitination promotes calpain cleavage of the protein phosphatase 2A (PP2A) regulatory subunit α4, altering PP2A stability and microtubule-associated protein phosphorylation. J. Biol. Chem. 287, 24207–24215 (2012).

    Article  CAS  Google Scholar 

  26. Sim, A.T., Ludowyke, R.I. & Verrills, N.M. Mast cell function: regulation of degranulation by serine/threonine phosphatases. Pharmacol. Ther. 112, 425–439 (2006).

    Article  CAS  Google Scholar 

  27. Cornell, T.T. et al. Ceramide-dependent PP2A regulation of TNFα-induced IL-8 production in respiratory epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 296, L849–L856 (2009).

    Article  CAS  Google Scholar 

  28. Shanley, T.P., Vasi, N., Denenberg, A. & Wong, H.R. The serine/threonine phosphatase, PP2A: endogenous regulator of inflammatory cell signaling. J. Immunol. 166, 966–972 (2001).

    Article  CAS  Google Scholar 

  29. Miskolci, V. et al. Okadaic acid induces sustained activation of NFκB and degradation of the nuclear IκBα in human neutrophils. Arch. Biochem. Biophys. 417, 44–52 (2003).

    Article  CAS  Google Scholar 

  30. Liu, W. et al. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways. J. Allergy Clin. Immunol. 121, 893–902.e2 (2008).

    Article  CAS  Google Scholar 

  31. Griego, S.D., Weston, C.B., Adams, J.L., Tal-Singer, R. & Dillon, S.B. Role of p38 mitogen-activated protein kinase in rhinovirus-induced cytokine production by bronchial epithelial cells. J. Immunol. 165, 5211–5220 (2000).

    Article  CAS  Google Scholar 

  32. Duan, W. et al. Inhaled p38α mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice. Am. J. Respir. Crit. Care Med. 171, 571–578 (2005).

    Article  Google Scholar 

  33. Wong, W.S. Inhibitors of the tyrosine kinase signaling cascade for asthma. Curr. Opin. Pharmacol. 5, 264–271 (2005).

    Article  CAS  Google Scholar 

  34. Das, J. et al. A critical role for NF-κB in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2, 45–50 (2001).

    Article  CAS  Google Scholar 

  35. Kobayashi, Y., Mercado, N., Barnes, P.J. & Ito, K. Defects of protein phosphatase 2a causes corticosteroid insensitivity in severe asthma. PLoS ONE 6, e27627 (2011).

    Article  CAS  Google Scholar 

  36. Don, A.S. et al. Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues. J. Biol. Chem. 282, 15833–15842 (2007).

    Article  CAS  Google Scholar 

  37. Francis, J.N., Sabroe, I., Lloyd, C.M., Durham, S.R. & Till, S.J. Elevated CCR6+ CD4+ T lymphocytes in tissue compared with blood and induction of CCL20 during the asthmatic late response. Clin. Exp. Immunol. 152, 440–447 (2008).

    Article  CAS  Google Scholar 

  38. Lambrecht, B.N. et al. Myeloid dendritic cells induce TH2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J. Clin. Invest. 106, 551–559 (2000).

    Article  CAS  Google Scholar 

  39. Ehrle, C. et al. Overexpressing mouse model demonstrates the protective role of Muc5ac in the lungs. Proc. Natl. Acad. Sci. USA. 109, 16528–16533 (2012).

    Article  Google Scholar 

  40. Xatzipsalti, M. & Papadopoulos, N.G. Cellular and animals models for rhinovirus infection in asthma. Contrib. Microbiol. 14, 33–41 (2007).

    Article  Google Scholar 

  41. Bartlett, N.W. et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat. Med. 14, 199–204 (2008).

    Article  CAS  Google Scholar 

  42. Collison, A., Mattes, J., Plank, M. & Foster, P.S. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J. Allergy Clin. Immunol. 128, 160–167 (2011).

    Article  CAS  Google Scholar 

  43. Sim, A.T., Collins, E., Mudge, L.M. & Rostas, J.A. Developmental regulation of protein phosphatase types 1 and 2A in post-hatch chicken brain. Neurochem. Res. 23, 487–491 (1998).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the National Health and Medical Research Council (NH&MRC 631075 and 1011153) (J.M., P.S.F., N.V.), the Hunter Medical Research Institute (J.M., P.A.B.W., P.S.F.), the Hunter Children's Research Foundation (J.M., P.S.F., A.P.d.S.) and an NH&MRC Health Practitioner Research Fellowship to J.M. (455623). N.W.B. was supported by a project grant from Asthma UK (06-050) and S.L.J. by a Chair from Asthma UK (CH1155). This work was supported in part by MRC Centre grant G1000758 and ERC FP7 Advanced grant 233015 (to S.L.J.). We would like to thank M. Smyth, Peter MacCallum Cancer Centre, and J. Peschon, Amgen, for providing Tnfsf10−/− mice and S. Akira, Osaka University, for providing Tlr4−/− and Myd88−/− mice. We appreciate technical assistance from C. Cesar de Souza Alves, F. Eyers, J. Girkin, J. Grehan, H. MacDonald, M. Morten, K. Parsons, S. Reeves, L. Sokulsky and the staff from the animal care facilities of the contributing institutes.

Author information

Authors and Affiliations

Authors

Contributions

A.C. and L.H. performed and designed mouse and cell culture experiments, analyzed data, generated figures and edited the manuscript. P.A.B.W. and M.T. performed and supervised studies on healthy subjects and subjects with asthma and performed cell culture experiments. N.V. and H.C. performed and analyzed PP2Ac measurements and immunoprecipitation and designed experiments. N.V. edited the manuscript. A.S.D. and J.C.M. synthesized AAL(S) for use as an activator of PP2A and developed the dosing regiment. N.Z. and M.E.R. coordinated and assisted in microarray array analysis. N.W.B. and S.L.J. assisted in design of experiments, provided RV1B for further propagation and cDNAs and edited the manuscript. A.P.d.S. coordinated and supervised mouse and human studies. P.S.F. supervised mouse studies, interpreted data and edited the manuscript. J.M. conceptualized, coordinated, designed and supervised mouse and human studies, interpreted and analyzed data, and drafted and edited the manuscript. All authors contributed to data discussion and revised the manuscript.

Corresponding author

Correspondence to Joerg Mattes.

Ethics declarations

Competing interests

J.M., A.C, L.H. and P.S.F. have filed a patent application under the Patent Cooperation Treaty that relates to the described data on MID1 function in this manuscript.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–7, Supplementary Table 1 and Supplementary Methods (PDF 1229 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Collison, A., Hatchwell, L., Verrills, N. et al. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat Med 19, 232–237 (2013). https://doi.org/10.1038/nm.3049

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.3049

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing